IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
37 hedge funds and large institutions have $8.67M invested in ImmunoCellular Therapeutics, Ltd. in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 14 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
-12
Holders Change %
-24.49%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
14
Closed
19
Calls
$724K
Puts
$2.52M
Net Calls
-$1.8M
Net Calls Change
-$2.1M
Top Buyers
Top Sellers
| 1 |
1
Northern Trust
Chicago,
Illinois
|
$226K |
| 2 |
2
Goldman Sachs
New York
|
$598K |
| 3 |
PP
3
Paloma Partners
Greenwich,
Connecticut
|
$0 |
| 4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NSIM
51
North Star Investment Management
Chicago,
Illinois
| – | -$39K | -500 | Closed |
|
52
JPMorgan Chase & Co
New York
| – | -$34K | -439 | Closed |
|
|
CAS
53
CTC Alternative Strategies
Chicago,
Illinois
| – | -$29.5K | -380 | Closed |
|
54
SG Americas Securities
New York
| – | -$25K | -318 | Closed |
|
|
TCIM
55
TIAA CREF Investment Management
New York
| – | -$19K | -245 | Closed |
|
56
California Public Employees Retirement System
Sacramento,
California
| – | -$3K | -45 | Closed |
|